Terms: = Breast cancer AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393 AND Prognosis
6 results:
1. Multi-omics of the expression and clinical outcomes of tmprss2 in human various cancers: A potential therapeutic target for COVID-19.
Liu L; Qin JF; Zuo MZ; Zhou Q
J Cell Mol Med; 2022 Feb; 26(3):709-724. PubMed ID: 34951103
[TBL] [Abstract] [Full Text] [Related]
2. Genetic Susceptibility of ACE2 and tmprss2 in Six Common cancers and Possible Impacts on COVID-19.
Hoang T; Nguyen TQ; Tran TTA
Cancer Res Treat; 2021 Jul; 53(3):650-656. PubMed ID: 33421977
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive analysis of two potential novel SARS-CoV-2 entries, tmprss2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract] [Full Text] [Related]
4. Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer.
Zeng W; Sun H; Meng F; Liu Z; Xiong J; Zhou S; Li F; Hu J; Hu Z; Liu Z
Int J Clin Exp Pathol; 2015; 8(2):1878-88. PubMed ID: 25973080
[TBL] [Abstract] [Full Text] [Related]
5. Type II transmembrane serine protease gene variants associate with breast cancer.
Luostari K; Hartikainen JM; Tengström M; Palvimo JJ; Kataja V; Mannermaa A; Kosma VM
PLoS One; 2014; 9(7):e102519. PubMed ID: 25029565
[TBL] [Abstract] [Full Text] [Related]
6. [Structural and functional analysis of tumor genomes and the development of test systems for early diagnosis, prognosis and cancer therapy optimization].
Zaletaev DV; Strel'nikov VV; Nemtsova MV; Babenko OV; Kuznetsova EB; Zemliakova VV; Kekeeva TV; Mikhaĭlenko DS; Tanas AS; Rudenko VV; Babaian AIu; Alekseeva EA; Simonova OA
Vestn Ross Akad Med Nauk; 2013; (9):7-14. PubMed ID: 24624866
[TBL] [Abstract] [Full Text] [Related]
